These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 21766492

  • 1. Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients.
    Saip R, Sen F, Vural B, Ugurel E, Demirkan A, Derin D, Eralp Y, Camlica H, Ustuner Z, Ozbek U.
    J BUON; 2011; 16(2):241-6. PubMed ID: 21766492
    [Abstract] [Full Text] [Related]

  • 2. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R.
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [Abstract] [Full Text] [Related]

  • 3. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
    Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY, Blumenschein GR, Hong WK, Wu X.
    Cancer; 2006 Jan 15; 106(2):441-7. PubMed ID: 16342067
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of glutathione S-transferase P1 polymorphisms (Ile105Val and Ala114Val) in patients with small cell lung cancer.
    Vural B, Yakar F, Derin D, Saip P, Yakar A, Demirkan A, Karabulut A, Ugurel E, Cine N, Kilicaslan Z, Tüzün E, Ozbek U.
    Genet Test Mol Biomarkers; 2012 Jul 15; 16(7):701-6. PubMed ID: 22339038
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
    Goekkurt E, Hoehn S, Wolschke C, Wittmer C, Stueber C, Hossfeld DK, Stoehlmacher J.
    Br J Cancer; 2006 Jan 30; 94(2):281-6. PubMed ID: 16317430
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC.
    Lung Cancer; 2006 Mar 30; 51(3):303-11. PubMed ID: 16406195
    [Abstract] [Full Text] [Related]

  • 7. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C, Nazar-Stewart V, Stapleton PL, Eaton DL, Vaughan TL.
    Cancer Epidemiol Biomarkers Prev; 2003 Jun 30; 12(6):527-33. PubMed ID: 12814998
    [Abstract] [Full Text] [Related]

  • 8. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
    Booton R, Ward T, Heighway J, Ashcroft L, Morris J, Thatcher N.
    J Thorac Oncol; 2006 Sep 30; 1(7):679-83. PubMed ID: 17409936
    [Abstract] [Full Text] [Related]

  • 9. An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma.
    Miller DP, Asomaning K, Liu G, Wain JC, Lynch TJ, Neuberg D, Su L, Christiani DC.
    Cancer; 2006 Oct 01; 107(7):1570-7. PubMed ID: 16933328
    [Abstract] [Full Text] [Related]

  • 10. Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
    Ji M, Xu B, Jiang JT, Wu J, Li XD, Zhao WQ, Zhang HY, Zhou WJ, Wu CP.
    Onkologie; 2013 Oct 01; 36(6):335-40. PubMed ID: 23774147
    [Abstract] [Full Text] [Related]

  • 11. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.
    Clin Cancer Res; 2000 May 01; 6(5):2075-86. PubMed ID: 10815935
    [Abstract] [Full Text] [Related]

  • 12. Radiotherapy in small-cell lung cancer: where should it go?
    Paumier A, Le Péchoux C.
    Lung Cancer; 2010 Aug 01; 69(2):133-40. PubMed ID: 20605651
    [Abstract] [Full Text] [Related]

  • 13. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M.
    J Clin Oncol; 2006 Sep 10; 24(26):4333-9. PubMed ID: 16896002
    [Abstract] [Full Text] [Related]

  • 14. Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro.
    Oshita F, Yamamoto N, Fukuda M, Ohe Y, Tamura T, Eguchi K, Shinkai T, Saijo N.
    Cancer Res; 1995 Jun 01; 55(11):2334-7. PubMed ID: 7757984
    [Abstract] [Full Text] [Related]

  • 15. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 16. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J, Chen P, Dai CH, Li XQ, Bao QL.
    Geriatr Gerontol Int; 2009 Jun 01; 9(2):172-82. PubMed ID: 19740361
    [Abstract] [Full Text] [Related]

  • 17. Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.
    Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J.
    Jpn J Clin Oncol; 2010 Oct 01; 40(10):954-60. PubMed ID: 20462983
    [Abstract] [Full Text] [Related]

  • 18. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA, Sloan JA, Rowland KM, Klee GG, Kugler JW, Mailliard JA, Wiesenfeld M, Krook JE, Maksymiuk AW, Shaw EG, Marks RS, Perez EA.
    Clin Cancer Res; 2000 Feb 01; 6(2):597-601. PubMed ID: 10690544
    [Abstract] [Full Text] [Related]

  • 19. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma.
    Hohaus S, Di Ruscio A, Di Febo A, Massini G, D'Alo' F, Guidi F, Mansueto G, Voso MT, Leone G.
    Clin Cancer Res; 2005 Mar 15; 11(6):2175-9. PubMed ID: 15788664
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V.
    Lung Cancer; 2006 Jul 15; 53(1):59-65. PubMed ID: 16716447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.